Novo Nordisk Share repurchase programme

On 15 August 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission’s regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.
Under the programme Novo Nordisk will repurchase B shares for an amount of up to DKK 1.7 billion in the period [...]

NMC Responds To House Of Lords Inquiry Into New Draft EU Directive On Patients’ Rights

NMC responds to House of Lords inquiry into new draft EU Directive on Patients’ Rights
The Nursing and Midwifery Council (NMC), the regulator for all nurses and midwives in the United Kingdom, has responded to a House of Lords Committee inquiry into the proposed EU Directive on the application of patients’ rights in cross-border healthcare.
The Social [...]

Initiation of Clinical Development Builds Upon Broad Potential Shown in Preclinical Studies

Infinity Pharmaceuticals, Inc. (NasdaqGM:INFI – News), an innovative cancer drug discovery and development company, today announced that it has initiated a Phase 1 clinical trial of its oral Hedgehog signaling pathway inhibitor, IPI-926, in patients with advanced and/or metastatic solid tumors.
IPI-926 is a novel, proprietary inhibitor of the Hedgehog signaling pathway. It is a derivative [...]

Edwards Lifesciences’ New Transcatheter Heart Valve Data Demonstrate Positive Results

Edwards Lifesciences Corporation, the world leader in the science of heart valves, announced that new data from two studies of the Edwards SAPIEN transcatheter aortic heart valve with the RetroFlex transfemoral delivery system were presented today at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
The 30-day results from [...]

Alarmed PRI Offers Resolution to EC to Reduce Road Accidents

Through a resolution, La Prevention Routiere Internationale has called for the European Commission to do everything possible to drastically reduce the number of casualties in traffic. Because of the fact that on the European roads this decrease lags behind significantly and even came to a stop in 2007, the PRI is of the opinion that [...]

Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease

An early proof-of-concept study presented today shows promising results for imatinib mesylate in the treatment of pulmonary arterial hypertension (PAH), a severe, incurable blood vessel disorder.
Preliminary findings from a 59-patient, multi-center Phase II clinical trial suggest imatinib mesylate provides a treatment benefit, as demonstrated by a significant improvement in pulmonary vascular resistance and a numerical [...]